FDA announces public meeting to discuss development and licensure of COVID-19 vaccines

The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on CutOct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.
Sending
User Review
0 (0 votes)

5 thoughts on “FDA announces public meeting to discuss development and licensure of COVID-19 vaccines

  1. What have you been up to? I am fascinated about covid19. Can you talk about it? If the same thread is opened please redirect my post :). Thanks :).

    PS: I don’t know any people with covid and you? rambo 😀

  2. What have you been up to? I am fascinated about covid19. Can you talk about it? If the same thread is opened please redirect my post :). Thanks :).
    I wrote once again – i cant see answer:)
    PS: I don’t know any people with covid and you? rambo 😀

Leave a Reply